C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/16 (2006.01) A61K 38/22 (2006.01) A61K 38/35 (2006.01) C07K 14/575 (2006.01) C07K 14/695 (2006.01) C07K 16/26 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2470731
Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
La présente invention concerne des dérivés isolés du facteur de libération de corticotropine, et des acides nucléiques codant pour de tels dérivés, efficaces dans le traitement de troubles modulés par le récepteur du facteur 2 de libération de la corticotropine tels que la dystrophie musculaire.
Isfort Robert Joseph
Mazur Wieslaw Adam
The Procter & Gamble Company
Torys Llp
Warner Chilcott Company Llc
LandOfFree
Corticotropin releasing factor 2 receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Corticotropin releasing factor 2 receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticotropin releasing factor 2 receptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1902862